We are live on ! Find out more
ONXX

ONYX PHARMACEUTICALS INC
ONXX

Delisted

ONXX was delisted on the 30th of September, 2013.

258 hedge funds and large institutions have $7.38B invested in ONYX PHARMACEUTICALS INC in 2013 Q3 according to their latest regulatory filings, with 83 funds opening new positions, 54 increasing their positions, 104 reducing their positions, and 95 closing their positions.

New
Increased
Maintained
Reduced
Closed

283% more funds holding in top 10

Funds holding in top 10: 1246 (+34)

55% more call options, than puts

Call options by funds: $1.26B | Put options by funds: $810M

5% less funds holding

Funds holding: 272258 (-14)

13% less first-time investments, than exits

New positions opened: 83 | Existing positions closed: 95

20% less capital invested

Capital invested by funds: $9.18B → $7.38B (-$1.8B)

48% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 104

Holders
258
Holders Change
-14
Holders Change %
-5.15%
% of All Funds
8.36%
Holding in Top 10
46
Holding in Top 10 Change
+34
Holding in Top 10 Change %
+283.33%
% of All Funds
1.49%
New
83
Increased
54
Reduced
104
Closed
95
Calls
$1.26B
Puts
$810M
Net Calls
+$448M
Net Calls Change
+$468M
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
51
Northern Trust
Illinois
$37.2M -$26.4M -208,102 -41%
AGC
52
Angelo Gordon & Co
New York
$34.3M +$34.8M +275,000 New
TCIM
53
TIAA CREF Investment Management
New York
$33.6M -$9.49M -74,942 -22%
WC
54
Wexford Capital
Florida
$31.6M +$32.1M +253,800 New
Millennium Management
55
Millennium Management
New York
$30.7M +$17M +134,555 +121%
GI
56
GLG Inc
New York
$30.3M +$30.7M +242,762 New
GCL
57
Glazer Capital LLC
New York
$29.6M +$30M +236,571 New
AC
58
Ascend Capital
California
$26.4M +$26.8M +211,714 New
VOAM
59
Vertex One Asset Management
British Columbia, Canada
$25.9M +$26.3M +208,000 New
ACM
60
Apex Capital Management
Ohio
$25.3M -$4.28M -33,823 -14%
PP
61
Paloma Partners
Connecticut
$24.9M +$24.2M +191,000 +2,122%
TCA
62
Taconic Capital Advisors
New York
$24.9M +$25.3M +200,000 New
ZDA
63
Zweig-DiMenna Associates
New York
$24.8M +$25.2M +198,810 New
MF
64
Magnetar Financial
Illinois
$24.3M +$24.6M +194,500 New
Sumitomo Mitsui Trust Group
65
Sumitomo Mitsui Trust Group
Japan
$23.8M +$1M +7,924 +4%
FMA
66
FNY Managed Accounts
New York
$23.3M +$23.7M +187,000 New
PCM
67
Proxima Capital Management
New York
$22.3M +$22.7M +179,000 New
DLPIC
68
Davide Leone & Partners Investment Company
United Kingdom
$21.9M +$22.2M +175,506 New
Franklin Resources
69
Franklin Resources
California
$21.2M -$131M -1,038,180 -86%
SAM
70
Sandell Asset Management
New York
$21.1M +$21.4M +169,287 New
CI
71
Cowen Inc
New York
$21.1M +$21.4M +168,961 New
ICM
72
Ionic Capital Management
New York
$20.8M +$21.1M +166,398 New
California Public Employees Retirement System
73
California Public Employees Retirement System
California
$20.5M +$219K +1,728 +1%
Dimensional Fund Advisors
74
Dimensional Fund Advisors
Texas
$20.3M -$45.5K -359 -0.2%
VanEck Associates
75
VanEck Associates
New York
$19.5M +$902K +7,121 +5%

ONXX Hedge Fund Activity: Q3 2013 in Review

258 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in ONYX PHARMACEUTICALS INC (ONXX) for Q3 2013, worth a combined $7.38B — down 20% from $9.18B a quarter earlier.

Sellers outnumbered buyers: 95 funds closed out of ONXX and 83 opened new positions — a net loss of 12 holders — while 104 trimmed existing stakes and 54 added.

The largest buyer was Davidson Kempner Capital Management, opening a new position worth an estimated $399M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $1.39B.

  • 258 institutional investors held ONYX PHARMACEUTICALS INC (ONXX) as of Q3 2013, down from 272 in Q2 2013.
  • Funds reported $7.38B of ONYX PHARMACEUTICALS INC stock for Q3 2013, down 20% quarter-over-quarter.
  • 83 funds opened new ONYX PHARMACEUTICALS INC positions in Q3 2013 and 95 closed out, a net change of -12 holders.
  • The largest ONYX PHARMACEUTICALS INC buyer in Q3 2013 was Davidson Kempner Capital Management, an estimated $399M added.
  • The largest ONYX PHARMACEUTICALS INC seller in Q3 2013 was BNP Paribas Financial Markets, an estimated $1.39B sold.

Based on aggregated 13F filings for Q3 2013.